Provider of physician staffing and services for neonatal, maternal-fetal and pediatric care in hospitals nationwide.
Provider of physician staffing and services for neonatal, maternal-fetal and pediatric care in hospitals nationwide.
Bills insurers and Medicaid for the care its doctors give, and receives supplemental payments from hospitals when billings alone do not cover staffing costs. A large share of neonatal patients are on Medicaid, so state rates matter. Formerly Mednax, it sold its radiology and anesthesia units in 2020 to focus on babies and pregnancies.
In one line: A hospital-based neonatal/pediatric physician staffing company.
Moat: narrow (scale, customer qualification). Large network of specialized neonatal/maternal-fetal physicians embedded in hospital contracts nationwide.
Headquarters: Sunrise, Florida · Founded: 1979 · Employees: 6,575
Size Pediatrix Medical (MD) is a United States Health Care company (Medical/Nursing Services) with a market value of $2.41B, the 1665th largest of 3,085 United States companies the cockpit tracks. Shares closed at $30.84 on 18 Nov 2026.
Performance Over six months the shares gained 37.2%, against +19.1% for the median peer and -2.2% for the United States market (cap-weighted) — 6th highest of 21 in its peer set.
Growth Revenue grew 1.9% over the last twelve months (peer median +7.9%); the operating margin is 12.2% (peer median 7.6%).
Valuation It trades at 12.4× forward earnings against a peer median of 37.6× (2nd cheapest of 17).
Price implies For today's price to make sense, revenue must grow about -4% a year for seven years (Req g). Recent delivered growth is +2%, so the hurdle is -6 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 10.5 points above its cost of capital (7.7% WACC).
Short interest Short interest is 4.5% of the free float (30 Oct 2026).
Next results Next results expected around 18 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $1.96B | $1.91B | $2.01B | $1.99B | $1.97B |
| Revenue growth | — | -5% | +1% | +1% | — |
| Gross profit | $488M | $472M | $422M | $385M | $431M |
| EBITDA | $262M | $253M | $216M | $194M | $236M |
| Net income | $150M | $165M | -$99.1M | -$60.4M | $66.3M |
| Free cash flow | $210M | $253M | $185M | $104M | $137M |
| Capital expenditure | $17.3M | $18.5M | $22.0M | $33.3M | $29.7M |
| Total debt | $612M | $635M | $662M | $702M | $717M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | MD | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +9.8% | -2.0% | 6th highest of 21 |
| 6-month return | +37.2% | +19.1% | 6th highest of 21 |
| Distance from 52-week high | -8.6% | -19.6% | 9th highest of 21 |
| Revenue growth (TTM) | +1.9% | +7.9% | 6th lowest of 21 |
| Operating margin | 12.2% | 7.6% | 5th highest of 21 |
| Forward P/E | 12.4× | 37.6× | 2nd cheapest of 17 |
| Growth the price implies (Req g, 7 yrs) | -4.4% | 13.6% | 2nd least demanding of 15 |
| Growth delivered (Del g) | +2.0% | +11.0% | 3rd lowest of 15 |
| Hurdle (Req g minus delivered) | -6.4 pp | +3.9 pp | 4th least demanding of 15 |
| ROIC minus cost of capital | +10.5 pp | -1.6 pp | 2nd highest of 20 |
| EV / EBITDA | 9.9× | 12.1× | 3rd cheapest of 14 |
| Net debt / EBITDA | 0.7× | 2.9× | 5th least indebted of 15 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Pediatrix Medical MD | United States | $2.41B | +37% | +2% | 12% | 12.4× | -4.4% | +2.0% |
| Aveanna Healthcare AVAH | United States | $2.37B | +41% | +17% | 12% | 12.2× | 7.7% | +10.2% |
| Addus HomeCare ADUS | United States | $2.25B | +29% | +12% | 11% | 16.2× | 4.0% | +13.2% |
| Meinian Onehealth Healthcare 002044.SZ | China | $2.60B | -27% | -4% | 9% | 49.6× | 4.2% | +5.7% |
| AddLife ALIF-B.ST | Sweden | $2.13B | +15% | +2% | 8% | 39.0× | 21.1% | +14.6% |
| Azenta AZTA | United States | $2.03B | +162% | +5% | -2% | 83.2× | 38.0% | +3.9% |
| NeoGenomics NEO | United States | $1.98B | +72% | +11% | -6% | 53.5× | n/a | n/a |
| Dr. Agarwal's Health Care AGARWALEYE.NS | India | $1.86B | +20% | +26% | 15% | 77.1× | 43.0% | +26.9% |
| Guangzhou Kingmed Diagnostics 603882.SS | China | $1.86B | +5% | -3% | 7% | 29.9× | 5.4% | -6.1% |
| Emeis EMEIS.PA | France | $1.78B | -33% | +4% | 3% | n/a | 21.2% | +8.5% |
| Dian Diagnostics 300244.SZ | China | $1.70B | +1% | -5% | 9% | 21.8× | 0.3% | -1.1% |
| Vijaya Diagnostic Centre VIJAYA.NS | India | $1.69B | +18% | +24% | 32% | 63.0× | 40.4% | +16.7% |
| Acadia Healthcare ACHC | United States | $3.49B | +56% | +4% | 10% | 18.6× | n/a | n/a |
| Dr. Lal PathLabs LALPATHLAB.NS | India | $3.53B | +15% | +17% | 24% | 50.5× | 32.3% | +11.8% |
| Personalis PSNL | United States | $1.62B | +88% | +17% | -157% | n/a | n/a | n/a |
| Sonida Senior Living SNDA | United States | $1.59B | -11% | +70% | -8% | n/a | n/a | n/a |
| Ambea AMBEA.ST | Sweden | $1.59B | +28% | +11% | 9% | 15.2× | 1.1% | +7.7% |
| GeneDx WGS | United States | $1.56B | +16% | +15% | -14% | 54.2× | n/a | n/a |
| agilon health AGL | United States | $1.52B | +12% | +2% | -2% | 34.1× | n/a | n/a |
| Medicover MCOV-B.ST | Sweden | $3.87B | +21% | +3% | 7% | 36.1× | 19.6% | +20.2% |
| Teladoc Health TDOC | United States | $1.47B | +24% | -2% | -5% | n/a | -6.4% | +18.3% |